| 000 | 01919 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250516195404.0 | ||
| 264 | 0 | _c20141218 | |
| 008 | 201412s 0 0 eng d | ||
| 022 | _a1873-5169 | ||
| 024 | 7 |
_a10.1016/j.peptides.2014.01.029 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSimonetti, Oriana | |
| 245 | 0 | 0 |
_aIn vitro activity and in vivo animal model efficacy of IB-367 alone and in combination with imipenem and colistin against Gram-negative bacteria. _h[electronic resource] |
| 260 |
_bPeptides _cMay 2014 |
||
| 300 |
_a17-22 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAcinetobacter baumannii _xdrug effects |
| 650 | 0 | 4 | _aAdministration, Topical |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
| 650 | 0 | 4 |
_aAntimicrobial Cationic Peptides _xadministration & dosage |
| 650 | 0 | 4 |
_aColistin _xadministration & dosage |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aEscherichia coli _xdrug effects |
| 650 | 0 | 4 |
_aGram-Negative Bacterial Infections _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImipenem _xadministration & dosage |
| 650 | 0 | 4 | _aInjections, Intraperitoneal |
| 650 | 0 | 4 |
_aKlebsiella pneumoniae _xdrug effects |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 |
_aPseudomonas aeruginosa _xdrug effects |
| 700 | 1 | _aCirioni, Oscar | |
| 700 | 1 | _aGhiselli, Roberto | |
| 700 | 1 | _aOrlando, Fiorenza | |
| 700 | 1 | _aSilvestri, Carmela | |
| 700 | 1 | _aMazzocato, Susanna | |
| 700 | 1 | _aKamysz, Wojciech | |
| 700 | 1 | _aKamysz, Elzbieta | |
| 700 | 1 | _aProvinciali, Mauro | |
| 700 | 1 | _aGiacometti, Andrea | |
| 700 | 1 | _aGuerrieri, Mario | |
| 700 | 1 | _aOffidani, Annamaria | |
| 773 | 0 |
_tPeptides _gvol. 55 _gp. 17-22 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.peptides.2014.01.029 _zAvailable from publisher's website |
| 999 |
_c23549013 _d23549013 |
||